{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:21Z","timestamp":1791928941161,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2016\/004795"],"award-info":[{"award-number":["EMR\/2016\/004795"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11033-020-05915-4","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T14:02:51Z","timestamp":1603375371000},"page":"9225-9234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Identification of an individual with a SYNGAP1 pathogenic mutation in India"],"prefix":"10.1007","volume":"47","author":[{"given":"Vijaya","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mandora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijeet","family":"Botre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7625-6430","authenticated-orcid":false,"given":"James P.","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"issue":"6","key":"5915_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa0805392","volume":"360","author":"FF Hamdan","year":"2009","unstructured":"Hamdan FF, Gauthier J, Spiegelman D, Noreau A, Yang Y, Pellerin S, Dobrzeniecka S, Cote M, Perreau-Linck E, Carmant L, D\u2019Anjou G, Fombonne E, Addington AM, Rapoport JL, Delisi LE, Krebs MO, Mouaffak F, Joober R, Mottron L, Drapeau P, Marineau C, Lafreniere RG, Lacaille JC, Rouleau GA, Michaud JL (2009) Synapse to disease G mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med 360(6):599\u2013605","journal-title":"N Engl J Med"},{"issue":"7304","key":"5915_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature09146","volume":"466","author":"D Pinto","year":"2010","unstructured":"Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, Almeida J, Bacchelli E, Bader GD, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, Bolte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Bryson SE, Carson AR, Casallo G, Casey J, Chung BH, Cochrane L, Corsello C, Crawford EL, Crossett A, Cytrynbaum C, Dawson G, de Jonge M, Delorme R, Drmic I, Duketis E, Duque F, Estes A, Farrar P, Fernandez BA, Folstein SE, Fombonne E, Freitag CM, Gilbert J, Gillberg C, Glessner JT, Goldberg J, Green A, Green J, Guter SJ, Hakonarson H, Heron EA, Hill M, Holt R, Howe JL, Hughes G, Hus V, Igliozzi R, Kim C, Klauck SM, Kolevzon A, Korvatska O, Kustanovich V, Lajonchere CM, Lamb JA, Laskawiec M, Leboyer M, Le Couteur A, Leventhal BL, Lionel AC, Liu XQ, Lord C, Lotspeich L, Lund SC, Maestrini E, Mahoney W, Mantoulan C, Marshall CR, McConachie H, McDougle CJ, McGrath J, McMahon WM, Merikangas A, Migita O, Minshew NJ, Mirza GK, Munson J, Nelson SF, Noakes C, Noor A, Nygren G, Oliveira G, Papanikolaou K, Parr JR, Parrini B, Paton T, Pickles A, Pilorge M, Piven J, Ponting CP, Posey DJ, Poustka A, Poustka F, Prasad A, Ragoussis J, Renshaw K, Rickaby J, Roberts W, Roeder K, Roge B, Rutter ML, Bierut LJ, Rice JP, Salt J, Sansom K, Sato D, Segurado R, Sequeira AF, Senman L, Shah N, Sheffield VC, Soorya L, Sousa I, Stein O, Sykes N, Stoppioni V, Strawbridge C, Tancredi R, Tansey K, Thiruvahindrapduram B, Thompson AP, Thomson S, Tryfon A, Tsiantis J, Van Engeland H, Vincent JB, Volkmar F, Wallace S, Wang K, Wang Z, Wassink TH, Webber C, Weksberg R, Wing K, Wittemeyer K, Wood S, Wu J, Yaspan BL, Zurawiecki D, Zwaigenbaum L, Buxbaum JD, Cantor RM, Cook EH, Coon H, Cuccaro ML, Devlin B, Ennis S, Gallagher L, Geschwind DH, Gill M, Haines JL, Hallmayer J, Miller J, Monaco AP, Nurnberger JI Jr, Paterson AD, Pericak-Vance MA, Schellenberg GD, Szatmari P, Vicente AM, Vieland VJ, Wijsman EM, Scherer SW, Sutcliffe JS, Betancur C (2010) Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466(7304):368\u2013372","journal-title":"Nature"},{"issue":"2","key":"5915_CR3","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1212\/WNL.0000000000006729","volume":"92","author":"DRM Vlaskamp","year":"2019","unstructured":"Vlaskamp DRM, Shaw BJ, Burgess R, Mei D, Montomoli M, Xie H, Myers CT, Bennett MF, XiangWei W, Williams D, Maas SM, Brooks AS, Mancini GMS, van de Laar I, van Hagen JM, Ware TL, Webster RI, Malone S, Berkovic SF, Kalnins RM, Sicca F, Korenke GC, van Ravenswaaij-Arts CMA, Hildebrand MS, Mefford HC, Jiang Y, Guerrini R, Scheffer IE (2019) SYNGAP1 encephalopathy: A distinctive generalised developmental and epileptic encephalopathy. Neurology 92(2):e96\u2013e107","journal-title":"Neurology"},{"issue":"7","key":"5915_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/ng.2646","volume":"45","author":"GL Carvill","year":"2013","unstructured":"Carvill GL, Heavin SB, Yendle SC, McMahon JM, O\u2019Roak BJ, Cook J, Khan A, Dorschner MO, Weaver M, Calvert S, Malone S, Wallace G, Stanley T, Bye AM, Bleasel A, Howell KB, Kivity S, Mackay MT, Rodriguez-Casero V, Webster R, Korczyn A, Afawi Z, Zelnick N, Lerman-Sagie T, Lev D, Moller RS, Gill D, Andrade DM, Freeman JL, Sadleir LG, Shendure J, Berkovic SF, Scheffer IE, Mefford HC (2013) Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet 45(7):825\u2013830","journal-title":"Nat Genet"},{"issue":"2","key":"5915_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/humu.22248","volume":"34","author":"MH Berryer","year":"2013","unstructured":"Berryer MH, Hamdan FF, Klitten LL, Moller RS, Carmant L, Schwartzentruber J, Patry L, Dobrzeniecka S, Rochefort D, Neugnot-Cerioli M, Lacaille JC, Niu Z, Eng CM, Yang Y, Palardy S, Belhumeur C, Rouleau GA, Tommerup N, Immken L, Beauchamp MH, Patel GS, Majewski J, Tarnopolsky MA, Scheffzek K, Hjalgrim H, Michaud JL, Di Cristo G (2013) Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency. Hum Mutat 34(2):385\u2013394","journal-title":"Hum Mutat"},{"issue":"3","key":"5915_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ajhg.2011.02.001","volume":"88","author":"FF Hamdan","year":"2011","unstructured":"Hamdan FF, Gauthier J, Araki Y, Lin DT, Yoshizawa Y, Higashi K, Park AR, Spiegelman D, Dobrzeniecka S, Piton A, Tomitori H, Daoud H, Massicotte C, Henrion E, Diallo O, Group SD, Shekarabi M, Marineau C, Shevell M, Maranda B, Mitchell G, Nadeau A, D\u2019Anjou G, Vanasse M, Srour M, Lafreniere RG, Drapeau P, Lacaille JC, Kim E, Lee JR, Igarashi K, Huganir RL, Rouleau GA, Michaud JL (2011) Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet. 88(3):306\u2013316","journal-title":"Am J Hum Genet."},{"issue":"12","key":"5915_CR7","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1111\/j.1528-1167.2011.03304.x","volume":"52","author":"LL Klitten","year":"2011","unstructured":"Klitten LL, Moller RS, Nikanorova M, Silahtaroglu A, Hjalgrim H, Tommerup N (2011) A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA). Epilepsia 52(12):e190-193","journal-title":"Epilepsia"},{"issue":"9","key":"5915_CR8","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1002\/ajmg.a.33554","volume":"152A","author":"AC Krepischi","year":"2010","unstructured":"Krepischi AC, Rosenberg C, Costa SS, Crolla JA, Huang S, Vianna-Morgante AM (2010) A novel de novo microdeletion spanning the SYNGAP1 gene on the short arm of chromosome 6 associated with mental retardation. Am J Med Genet A 152A(9):2376\u20132378","journal-title":"Am J Med Genet A"},{"issue":"2","key":"5915_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ejhg.2010.172","volume":"19","author":"M Zollino","year":"2011","unstructured":"Zollino M, Gurrieri F, Orteschi D, Marangi G, Leuzzi V, Neri G (2011) Integrated analysis of clinical signs and literature data for the diagnosis and therapy of a previously undescribed 6p21.3 deletion syndrome. Eur J Hum Genet 19(2):239\u2013242","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"5915_CR10","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/ajmg.a.35930","volume":"161A","author":"K Writzl","year":"2013","unstructured":"Writzl K, Knegt AC (2013) 6p21.3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment. Am J Med Genet A 161A(7):1682\u20131685","journal-title":"Am J Med Genet A"},{"issue":"4","key":"5915_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0896-6273(00)81008-9","volume":"20","author":"JH Kim","year":"1998","unstructured":"Kim JH, Liao D, Lau LF, Huganir RL (1998) SynGAP: a synaptic RasGAP that associates with the PSD-95\/SAP90 protein family. Neuron 20(4):683\u2013691","journal-title":"Neuron"},{"key":"5915_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fncel.2016.00032","volume":"10","author":"N Jeyabalan","year":"2016","unstructured":"Jeyabalan N, Clement JP (2016) SYNGAP1: mind the gap. Front Cell Neurosci 10:32","journal-title":"Front Cell Neurosci"},{"key":"5915_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neuroscience.2011.06.061","volume":"192","author":"Y Yang","year":"2011","unstructured":"Yang Y, Tao-Cheng JH, Reese TS, Dosemeci A (2011) SynGAP moves out of the core of the post-synaptic density upon depolarisation. Neuroscience 192:132\u2013139","journal-title":"Neuroscience"},{"issue":"12","key":"5915_CR14","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1073\/pnas.0600084103","volume":"103","author":"G Rumbaugh","year":"2006","unstructured":"Rumbaugh G, Adams JP, Kim JH, Huganir RL (2006) SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. Proc Natl Acad Sci U S A 103(12):4344\u20134351","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5915_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1460-9568.2005.03874.x","volume":"21","author":"K Porter","year":"2005","unstructured":"Porter K, Komiyama NH, Vitalis T, Kind PC, Grant SG (2005) Differential expression of two NMDA receptor interacting proteins, PSD-95 and SynGAP during mouse development. Eur J Neurosci 21(2):351\u2013362","journal-title":"Eur J Neurosci"},{"issue":"4","key":"5915_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cell.2012.08.045","volume":"151","author":"JP Clement","year":"2012","unstructured":"Clement JP, Aceti M, Creson TK, Ozkan ED, Shi Y, Reish NJ, Almonte AG, Miller BH, Wiltgen BJ, Miller CA, Xu X, Rumbaugh G (2012) Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell 151(4):709\u2013723","journal-title":"Cell"},{"issue":"25","key":"5915_CR17","doi-asserted-by":"publisher","first-page":"10447","DOI":"10.1523\/JNEUROSCI.0765-13.2013","volume":"33","author":"JP Clement","year":"2013","unstructured":"Clement JP, Ozkan ED, Aceti M, Miller CA, Rumbaugh G (2013) SYNGAP1 links the maturation rate of excitatory synapses to the duration of critical-period synaptic plasticity. J Neurosci 33(25):10447\u201310452","journal-title":"J Neurosci"},{"key":"5915_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fnmol.2019.00097","volume":"12","author":"A Paul","year":"2019","unstructured":"Paul A, Nawalpuri B, Shah D, Sateesh S, Muddashetty RS, Clement JP (2019) Differential regulation of Syngap1 translation by FMRP modulates eEF2 mediated response on NMDAR activity. Front Mol Neurosci 12:97","journal-title":"Front Mol Neurosci"},{"issue":"7","key":"5915_CR19","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/npp.2008.223","volume":"34","author":"X Guo","year":"2009","unstructured":"Guo X, Hamilton PJ, Reish NJ, Sweatt JD, Miller CA, Rumbaugh G (2009) Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia. Neuropsychopharmacology 34(7):1659\u20131672","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"5915_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/npr2.12073","volume":"39","author":"R Nakajima","year":"2019","unstructured":"Nakajima R, Takao K, Hattori S, Shoji H, Komiyama NH, Grant SGN, Miyakawa T (2019) Comprehensive behavioral analysis of heterozygous Syngap1 knockout mice. Neuropsychopharmacol Rep 39(3):223\u2013237","journal-title":"Neuropsychopharmacol Rep"},{"issue":"8","key":"5915_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrneurol.2016.98","volume":"12","author":"KC Nickels","year":"2016","unstructured":"Nickels KC, Zaccariello MJ, Hamiwka LD, Wirrell EC (2016) Cognitive and neurodevelopmental comorbidities in paediatric epilepsy. Nat Rev Neurol 12(8):465\u2013476","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"5915_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/cap.2018.0159","volume":"29","author":"EH Cook","year":"2019","unstructured":"Cook EH, Masaki JT, Guter SJ, Najjar F (2019) Lovastatin treatment of a patient with a De Novo SYNGAP1 protein truncating variant. J Child Adolesc Psychopharmacol 29(4):321\u2013322","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"5915_CR23","doi-asserted-by":"publisher","first-page":"180265","DOI":"10.1098\/rsob.180265","volume":"9","author":"V Verma","year":"2019","unstructured":"Verma V, Paul A, Amrapali Vishwanath A, Vaidya B, Clement JP (2019) Understanding intellectual disability and autism spectrum disorders from common mouse models: synapses to behaviour. Open Biol 9(6):180265","journal-title":"Open Biol"},{"issue":"6609","key":"5915_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/384591a0","volume":"384","author":"K Scheffzek","year":"1996","unstructured":"Scheffzek K, Lautwein A, Kabsch W, Ahmadian MR, Wittinghofer A (1996) Crystal structure of the GTPase-activating domain of human p120GAP and implications for the interaction with Ras. Nature 384(6609):591\u2013596","journal-title":"Nature"},{"issue":"5324","key":"5915_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1126\/science.277.5324.333","volume":"277","author":"K Scheffzek","year":"1997","unstructured":"Scheffzek K, Ahmadian MR, Kabsch W, Wiesmuller L, Lautwein A, Schmitz F, Wittinghofer A (1997) The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 277(5324):333\u2013338","journal-title":"Science"},{"issue":"1","key":"5915_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0014-5793(97)00321-9","volume":"410","author":"A Wittinghofer","year":"1997","unstructured":"Wittinghofer A, Scheffzek K, Ahmadian MR (1997) The interaction of Ras with GTPase-activating proteins. FEBS Lett 410(1):63\u201367","journal-title":"FEBS Lett"},{"issue":"5","key":"5915_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0896-6273(00)80471-7","volume":"20","author":"HJ Chen","year":"1998","unstructured":"Chen HJ, Rojas-Soto M, Oguni A, Kennedy MB (1998) A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. Neuron 20(5):895\u2013904","journal-title":"Neuron"},{"issue":"8","key":"5915_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/jmedgenet-2015-103451","volume":"53","author":"C Mignot","year":"2016","unstructured":"Mignot C, von Stulpnagel C, Nava C, Ville D, Sanlaville D, Lesca G, Rastetter A, Gachet B, Marie Y, Korenke GC, Borggraefe I, Hoffmann-Zacharska D, Szczepanik E, Rudzka-Dybala M, Yis U, Caglayan H, Isapof A, Marey I, Panagiotakaki E, Korff C, Rossier E, Riess A, Beck-Woedl S, Rauch A, Zweier C, Hoyer J, Reis A, Mironov M, Bobylova M, Mukhin K, Hernandez-Hernandez L, Maher B, Sisodiya S, Kuhn M, Glaeser D, Weckhuysen S, Myers CT, Mefford HC, Hortnagel K, Biskup S, Euro E-RESMAEwg, Lemke JR, Heron D, Kluger G, Depienne C (2016) Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy. J Med Genet 53(8):511\u2013522","journal-title":"J Med Genet"},{"issue":"6","key":"5915_CR29","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0022-2275(20)40110-5","volume":"35","author":"LF Berglund","year":"1994","unstructured":"Berglund LF, Beltz WF, Elam RL, Witztum JL (1994) Altered apolipoprotein B metabolism in very low density lipoprotein from lovastatin-treated guinea pigs. J Lipid Res 35(6):956\u2013965","journal-title":"J Lipid Res"},{"issue":"4746","key":"5915_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1126\/science.3513311","volume":"232","author":"MS Brown","year":"1986","unstructured":"Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232(4746):34\u201347","journal-title":"Science"},{"issue":"12","key":"5915_CR31","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/S0022-2275(20)42109-1","volume":"31","author":"E Reihner","year":"1990","unstructured":"Reihner E, Angelin B, Rudling M, Ewerth S, Bjorkhem I, Einarsson K (1990) Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. J Lipid Res 31(12):2219\u20132226","journal-title":"J Lipid Res"},{"issue":"4","key":"5915_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJM199007263230403","volume":"323","author":"E Reihner","year":"1990","unstructured":"Reihner E, Rudling M, Stahlberg D, Berglund L, Ewerth S, Bjorkhem I, Einarsson K, Angelin B (1990) Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med 323(4):224\u2013228","journal-title":"N Engl J Med"},{"issue":"10","key":"5915_CR33","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1345\/aph.17231","volume":"32","author":"HS Yee","year":"1998","unstructured":"Yee HS, Fong NT (1998) Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias. Ann Pharmacother 32(10):1030\u20131043","journal-title":"Ann Pharmacother"},{"issue":"2","key":"5915_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/107424849600100205","volume":"1","author":"TM Heinonen","year":"1996","unstructured":"Heinonen TM, Schrott H, McKenney JM, Sniderman AD, Broyles FE, Zavoral JH, Kivel F, Black DM (1996) Atorvastatin, a new HMG-CoA reductase inhibitor as monotherapy and combined with colestipol. J Cardiovasc Pharmacol Ther 1(2):117\u2013122","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"5","key":"5915_CR35","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0149-2918(96)80045-2","volume":"18","author":"TM Heinonen","year":"1996","unstructured":"Heinonen TM, Stein E, Weiss SR, McKenney JM, Davidson M, Shurzinske L, Black DM (1996) The lipid-lowering effects of Atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomised, double-masked study. Clin Ther 18(5):853\u2013863","journal-title":"Clin Ther"},{"issue":"5","key":"5915_CR36","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/01.ATV.15.5.678","volume":"15","author":"JW Nawrocki","year":"1995","unstructured":"Nawrocki JW, Weiss SR, Davidson MH, Sprecher DL, Schwartz SL, Lupien PJ, Jones PH, Haber HE, Black DM (1995) Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by Atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol 15(5):678\u2013682","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"5915_CR37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s12035-014-9030-0","volume":"53","author":"SH Lee","year":"2016","unstructured":"Lee SH, Choi NY, Yu HJ, Park J, Choi H, Lee KY, Huh YM, Lee YJ, Koh SH (2016) Atorvastatin protects NSC-34 motor neurons against oxidative stress by activating PI3K, ERK and free radical scavenging. Mol Neurobiol 53(1):695\u2013705","journal-title":"Mol Neurobiol"},{"issue":"7","key":"5915_CR38","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/aps.2012.59","volume":"33","author":"Y Jin","year":"2012","unstructured":"Jin Y, Sui HJ, Dong Y, Ding Q, Qu WH, Yu SX, Jin YX (2012) Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt\/mTOR and Akt\/GSK-3beta signaling pathways. Acta Pharmacol Sin 33(7):861\u2013872","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"5915_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","volume":"19","author":"M Schachter","year":"2005","unstructured":"Schachter M (2005) Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol 19(1):117\u2013125","journal-title":"Fundam Clin Pharmacol"},{"issue":"19","key":"5915_CR40","doi-asserted-by":"publisher","first-page":"18755","DOI":"10.1074\/jbc.M413895200","volume":"280","author":"SL Cole","year":"2005","unstructured":"Cole SL, Grudzien A, Manhart IO, Kelly BL, Oakley H, Vassar R (2005) Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism. J Biol Chem 280(19):18755\u201318770","journal-title":"J Biol Chem"},{"issue":"5","key":"5915_CR41","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.neuron.2011.04.001","volume":"70","author":"SE Kwon","year":"2011","unstructured":"Kwon SE, Chapman ER (2011) Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons. Neuron 70(5):847\u2013854","journal-title":"Neuron"},{"issue":"6","key":"5915_CR42","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/joim.12838","volume":"284","author":"B Petek","year":"2018","unstructured":"Petek B, Villa-Lopez M, Loera-Valencia R, Gerenu G, Winblad B, Kramberger MG, Ismail MA, Eriksdotter M, Garcia-Ptacek S (2018) Connecting the brain cholesterol and renin-angiotensin systems: potential role of statins and RAS-modifying medications in dementia. J Intern Med 284(6):620\u2013642","journal-title":"J Intern Med"},{"issue":"12","key":"5915_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.4140\/TCP.n.2018.706.","volume":"33","author":"TN Downs","year":"2018","unstructured":"Downs TN (2018) Statins: the burglar of memory? Consult Pharm 33(12):706\u2013710","journal-title":"Consult Pharm"},{"key":"5915_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbr.2014.03.014","volume":"267","author":"JM Schilling","year":"2014","unstructured":"Schilling JM, Cui W, Godoy JC, Risbrough VB, Niesman IR, Roth DM, Patel PM, Drummond JC, Patel HH, Zemljic-Harpf AE, Head BP (2014) Long-term atorvastatin treatment leads to alterations in behavior, cognition, and hippocampal biochemistry. Behav Brain Res 267:6\u201311","journal-title":"Behav Brain Res"},{"key":"5915_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ahj.2017.10.027","volume":"197","author":"BA Taylor","year":"2018","unstructured":"Taylor BA, Dager AD, Panza GA, Zaleski AL, Meda S, Book G, Stevens MC, Tartar S, White CM, Polk DM, Pearlson GD, Thompson PD (2018) The effect of high-dose Atorvastatin on neural activity and cognitive function. Am Heart J 197:166\u2013174","journal-title":"Am Heart J"},{"key":"5915_CR46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ahj.2017.12.003","volume":"197","author":"JN Browndyke","year":"2018","unstructured":"Browndyke JN, Heflin MT (2018) Cognition and brain changes associated with high-dose Atorvastatin: a BOLD proposition? Am Heart J 197:163\u2013165","journal-title":"Am Heart J"}],"updated-by":[{"DOI":"10.1007\/s11033-021-06649-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000}}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05915-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05915-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05915-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:08:04Z","timestamp":1634861284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05915-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5915"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05915-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11033-021-06649-7","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"2 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no Conflict interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All procedures performed in studies involving human participant were in accordance with the ethical standards of the institutional and\/or national research committee (JNCASR-Institute Ethical Committee) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving Human Participants and\/or Animals"}},{"value":"Informed consent was obtained from all individual participants included in the study. In this case, the parents provided written informed consent, for themselves and the child patient, for the publication of identifying images or other personal or clinical details of participant that may compromise anonymity.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}